The GINA 2026 update covers primary care management of asthma exacerbations, fatality risk factors, biologic selection, and ...

Why should people with blue inhalers switch? "Over a million people have been switched from using the standard blue inhaler ...

PARIS — Pregnancy is a period of asthma instability; it entails an increased risk for exacerbations. While therapeutic de-escalation, if not the outright cessation of maintenance treatment, is common, ...

A peak flow meter is a simple, small, hand-held tool that can help you maintain control of asthma by providing a measurement of how well air moves out of the lungs. After blowing into the device, the ...

Asthma is common. Around 10 percent of Americans have the condition, with hundreds of millions more asthmatics worldwide. Though the ubiquity of asthma may be concerning in and of itself, it's a ...

A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase 2 trials of the drug signal, and why it shows promise for better asthma ...

Initiation of biologic treatment for asthma is low despite availability, and adherence is low as well despite its association ...

Most people living with severe asthma are also battling other health conditions that go under the radar, a major new study ...

Learn how the asthma drug montelukast helped restore immune attacks against tumors in several cancer types.